When you google the phrase “stem cell therapy for MS“, it can feel like you fell into a black hole of conflicting information, misinformation, and dodgy information that can be full of promises designed to speak directly to someone who is anxiously and sometimes desperately looking for a miracle cure for a debilitating condition. And there's also plenty of good, credible information available online. But how do you go about separating the wheat from the chaff? We're going to try to jump start that process for you in this podcast episode, as we look at the current state of stem cell therapy & MS.
We're also discussing the latest news about Ocrevus, medical cannabis for MS, a clinical trial that's recruiting 900 people recently diagnosed with relapsing-remitting MS, a couple of new apps to help you manage MS, and a webinar about maintaining your independence with progressive MS.
We have a lot to talk about! Are you ready for RealTalk MS?
U.K. Approves Ocrevus for RRMS 2:12
MMJ Bioscience Seeks FDA Approval for Cannabis Phase II Clinical Trial 3:48
Biogen Adds MS & Cognition Resource Center to MyMSTeam 5:20
Biogen Releases Aby, an App for People Living with MS 6:30
Nationwide Clinical Trial Recruiting People Newly Diagnosed with MS 9:10
Roche & EAN Produces “Maintaining Independence in Progressive MS” Webinar 11:08
Stem Cell Therapy & MS 12:38
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com
RealTalk MS Episode 42
Hosted By: Jon Strum
Tags: MS, MultipleSclerosis, MSResearch, Ocrevus, MyMSTeam, Biogen, Aby, HopkinsMedicine, ProgressiveMS, HSCT, RealTalkMS